CJC-1295 (no DAC) + Ipamorelin Blend 10MG (CJC-1295 + IPA Blend)
A blended research vial pairing a GHRH analog (CJC-1295 without DAC) with a selective growth hormone releasing peptide (Ipamorelin) for investigation of pulsatile GH release, dual GHRH/GHRP signaling, and endocrine pathway research. For CJC-1295 (no DAC) + Ipamorelin Blend, each vial is labeled 10MG, CAS Blend (863288-34-0 · 170851-70-4).
Published laboratory work with CJC-1295 (no DAC) + Ipamorelin Blend has examined pulsatile growth hormone axis, dual ghrh/ghrp signaling studies, endocrine pathway research models. Each lot is third-party tested by an independent analytical laboratory: purity by reverse-phase HPLC area percent and identity by mass spectrometry, reported on the lot certificate of analysis.
Supplied for in-vitro laboratory research use only. Not for human or veterinary consumption, administration, diagnostic or therapeutic use.
Combination of CJC-1295 (GHRH analog) and Ipamorelin (GHRP) commonly researched together for pulsatile growth hormone axis studies.
Background reading on this compound in the ENOS Lab Notes: CJC-1295 and Ipamorelin: A Comparative Review of Research Applications.
How this lot is verified and handled: Peptide Purity Testing and How to Read a Certificate of Analysis, HPLC vs Mass Spectrometry: What Each Test Actually Proves and Reconstitution and Storage Handling for Lyophilized Research Peptides.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Compound identity
Listed on the storefront as CJC-1295 + IPA Blend. The verified compound identity for this research vial is below.
- Compound name
- CJC-1295 (no DAC) + Ipamorelin Blend
- Molecular formula
- Blend — see individual components
- Molecular weight
- Blend — see individual components
- CAS number
- Blend (863288-34-0 · 170851-70-4)
- Vial size
- 10MG
Product Information
Research DatasheetProduct Overview
A blended research vial pairing a GHRH analog (CJC-1295 without DAC) with a selective growth hormone releasing peptide (Ipamorelin) for investigation of pulsatile GH release, dual GHRH/GHRP signaling, and endocrine pathway research. Lyophilized under sterile conditions and third-party tested. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Pulsatile growth hormone axis research
- ◆Dual GHRH/GHRP signaling studies
- ◆Endocrine pathway research models
- ◆Comparative secretagogue pharmacology
- ◆Peptide blend stability research
Quality Standards
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Combination of CJC-1295 (GHRH analog) and Ipamorelin (GHRP) commonly researched together for pulsatile growth hormone axis studies. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like
HGH
HGH · 10 × 10IU Kit
Recombinant human growth hormone research kit — 10 vials, 99% purity.
HGH 191AA
HGH 191AA · 10 × 15IU Kit
Recombinant human growth hormone research kit — 10 × 15IU, 99% purity.
HGH 191AA
HGH 191AA · 10 × 24IU Kit
Highest-yield HGH 191AA research kit — 10 × 24IU, 99% purity.
Tesamorelin
Tesamorelin · 10MG
Clinically researched peptide studied for natural growth hormone release.